Finzati - Logo
CURX logo

Curanex Pharmaceuticals Inc Common Stock

CURX • Biotechnology
$4.76
▼ -0.16 (-3.15%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.16M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 81.93Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:19 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.77
Change-3.15%
Market Cap$6.16M
52W Range0.18 - 9.18
Beta-2.74
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio81.93
Quick Ratio81.93
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 81.93Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/26/2025
Industry: Biotechnology
P/B i: 0.75
Debt / Equity i: 0.03
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.03
Current Ratio: 81.93
Quick Ratio: 81.93
Status: Strong

Insider Transactions

Recent executive and insider activity

Jing Dian Ying
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER
Jing Dian Ying
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER
Liu Chang
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER